Health
Anthropic Just Became a Biotech: The Week AI Medicine Stopped Being a Pilot Program
Anthropic launched Claude Science and announced it will develop its own drugs. NVIDIA integrated BioNeMo into the platform. A patent for AI-native biology was filed. And industry confidence just hit a tipping point. This is the week AI in medicine stopped being a pilot program.
Lavamgam AIJul 2, 20265 min read read
The Signal
On Tuesday, Anthropic stood before a room of pharmaceutical executives and biotech founders in San Francisco and announced it was no longer content to just build models for drug discovery. The company unveiled Claude Science, an AI workbench for biological research, and quietly confirmed it would use the tool to start discovering drugs of its own—starting with therapies for rare, neglected diseases. An AI company worth nearly a trillion dollars just became a biotech.
Zoom...
Anthropic
Claude Science
AI drug discovery
NVIDIA BioNeMo
healthcare AI
biotech
pharmaceutical AI
MindWalk
Share